Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport
- PMID: 11358373
- DOI: 10.1006/bcmd.2000.0356
Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport
Abstract
Thiamine-responsive megaloblastic anemia (TRMA) syndrome (OMIM No. 249270) comprises a distinctive triad of clinical features: megaloblastic anemia with ringed sideroblasts, diabetes mellitus, and progressive sensorineural deafness. The TRMA gene has been mapped and cloned. Designated "SLC19A2" as a member of the solute carrier gene superfamily, this gene is mutated in all TRMA kindreds studied to date. The product of the SLC19A2 gene is a membrane protein which transports thiamine (vitamin B1) with sub-micromolar affinity. Cells from TRMA patients are uniquely sensitive to thiamine depletion to the nanomolar range, while pharmacologic doses of vitamin B1 ameliorate the anemia and diabetes. Here we review the current status of studies aimed at understanding the pathophysiology of this unique transport defect.
Copyright 2001 Academic Press.
Similar articles
-
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.Nat Genet. 1999 Jul;22(3):305-8. doi: 10.1038/10379. Nat Genet. 1999. PMID: 10391222
-
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.Nat Genet. 1999 Jul;22(3):309-12. doi: 10.1038/10385. Nat Genet. 1999. PMID: 10391223
-
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.Nat Genet. 1999 Jul;22(3):300-4. doi: 10.1038/10372. Nat Genet. 1999. PMID: 10391221
-
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.Pediatr Diabetes. 2012 Jun;13(4):314-21. doi: 10.1111/j.1399-5448.2012.00855.x. Epub 2012 Feb 27. Pediatr Diabetes. 2012. PMID: 22369132 Review.
-
Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome.Pediatr Cardiol. 2003 Sep-Oct;24(5):476-81. doi: 10.1007/s00246-002-0215-3. Pediatr Cardiol. 2003. PMID: 14627317 Review.
Cited by
-
Developmental maturation of the colonic uptake process of the microbiota-generated thiamin pyrophosphate.Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G829-G835. doi: 10.1152/ajpgi.00067.2021. Epub 2021 Mar 24. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 33759569 Free PMC article.
-
Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):199-201. doi: 10.4274/Jcrpe.969. J Clin Res Pediatr Endocrinol. 2013. PMID: 24072090 Free PMC article.
-
Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.Eur J Pediatr. 2012 Nov;171(11):1711-5. doi: 10.1007/s00431-012-1730-8. Epub 2012 May 11. Eur J Pediatr. 2012. PMID: 22576805
-
Nutrient transport in the mammary gland: calcium, trace minerals and water soluble vitamins.J Mammary Gland Biol Neoplasia. 2014 Mar;19(1):73-90. doi: 10.1007/s10911-014-9317-9. Epub 2014 Feb 25. J Mammary Gland Biol Neoplasia. 2014. PMID: 24567109 Review.
-
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.Mol Aspects Med. 2013 Apr-Jun;34(2-3):373-85. doi: 10.1016/j.mam.2012.07.006. Mol Aspects Med. 2013. PMID: 23506878 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
